Atlas Trials

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Clinical trial NCT01190189 · COMPLETED

Trial details

NCT number
NCT01190189
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infections, Papillomavirus
Start date
2011-04-01
Primary completion
2017-11-23
Enrollment
137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.